{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T01:19:52Z","timestamp":1793755192451,"version":"4.6.1"},"reference-count":37,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,4]],"date-time":"2025-09-04T00:00:00Z","timestamp":1756944000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R00HD096115"],"award-info":[{"award-number":["R00HD096115"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009833","name":"Columbus Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009833","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011500","name":"Research Institute, Nationwide Children's Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011500","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["T32TR004543"],"award-info":[{"award-number":["T32TR004543"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["TL1TR002735"],"award-info":[{"award-number":["TL1TR002735"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["UM1TR004548"],"award-info":[{"award-number":["UM1TR004548"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006928","name":"Ohio State University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006928","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016618","name":"Gilbert Family Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016618","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy Methods & Clinical Development"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.omtm.2025.101588","type":"journal-article","created":{"date-parts":[[2025,9,5]],"date-time":"2025-09-05T17:42:18Z","timestamp":1757094138000},"page":"101588","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Comparative analysis of cell-specific promoters in AAV9-mediated gene therapy targeting the central nervous system"],"prefix":"10.1016","volume":"33","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2780-2228","authenticated-orcid":false,"given":"Sergiy","family":"Chornyy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica A.","family":"Herstine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caleb","family":"Holaway","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abigail","family":"Biddle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatyana A.","family":"Vetter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nettie K.","family":"Pyne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8268-3743","authenticated-orcid":false,"given":"Allison M.","family":"Bradbury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.omtm.2025.101588_bib1","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1038\/s41586-018-0566-4","article-title":"Common genetic variants contribute to risk of rare severe neurodevelopmental disorders","volume":"562","author":"Niemi","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.omtm.2025.101588_bib2","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/s12920-018-0362-x","article-title":"Burden of de novo mutations and inherited rare single nucleotide variants in children with sensory processing dysfunction","volume":"11","author":"Marco","year":"2018","journal-title":"BMC Med. Genomics"},{"key":"10.1016\/j.omtm.2025.101588_bib3","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.jconrel.2023.01.067","article-title":"AAV vectors applied to the treatment of CNS disorders: Clinical status and challenges","volume":"355","author":"Kang","year":"2023","journal-title":"J. Control. Release"},{"key":"10.1016\/j.omtm.2025.101588_bib4","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1038\/s41573-023-00766-7","article-title":"AAV-based in vivo gene therapy for neurological disorders","volume":"22","author":"Ling","year":"2023","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.omtm.2025.101588_bib5","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s11689-018-9234-0","article-title":"Recent progress and considerations for AAV gene therapies targeting the central nervous system","volume":"10","author":"Lykken","year":"2018","journal-title":"J. Neurodev. Disord."},{"key":"10.1016\/j.omtm.2025.101588_bib6","doi-asserted-by":"crossref","first-page":"4906","DOI":"10.1172\/JCI133953","article-title":"Krabbe disease successfully treated via monotherapy of intrathecal gene therapy","volume":"130","author":"Bradbury","year":"2020","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.omtm.2025.101588_bib7","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1016\/j.ymthe.2024.03.034","article-title":"Evaluation of safety and early efficacy of AAV gene therapy in mouse models of vanishing white matter disease","volume":"32","author":"Herstine","year":"2024","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2025.101588_bib8","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1002\/glia.20622","article-title":"GFAP promoter elements required for region-specific and astrocyte-specific expression","volume":"56","author":"Lee","year":"2008","journal-title":"Glia"},{"key":"10.1016\/j.omtm.2025.101588_bib9","doi-asserted-by":"crossref","first-page":"2767","DOI":"10.1016\/j.ymthe.2023.07.013","article-title":"Novel MECP2 gene therapy is effective in a multicenter study using two mouse models of Rett syndrome and is safe in non-human primates","volume":"31","author":"Powers","year":"2023","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2025.101588_bib10","doi-asserted-by":"crossref","first-page":"93","DOI":"10.3389\/fnana.2019.00093","article-title":"Adeno-Associated Virus Technologies and Methods for Targeted Neuronal Manipulation","volume":"13","author":"Haery","year":"2019","journal-title":"Front. Neuroanat."},{"key":"10.1016\/j.omtm.2025.101588_bib11","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.ymthe.2005.08.012","article-title":"Equal potency of gammaretroviral and lentiviral SIN vectors for expression of O6-methylguanine\u2013DNA methyltransferase in hematopoietic cells","volume":"13","author":"Schambach","year":"2006","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2025.101588_bib12","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.125052","article-title":"Gene suppressing therapy for Pelizaeus-Merzbacher disease using artificial microRNA","volume":"4","author":"Li","year":"2019","journal-title":"JCI Insight"},{"key":"10.1016\/j.omtm.2025.101588_bib13","doi-asserted-by":"crossref","first-page":"13","DOI":"10.3389\/fnmol.2016.00013","article-title":"Recombinant Human Myelin-Associated Glycoprotein Promoter Drives Selective AAV-Mediated Transgene Expression in Oligodendrocytes","volume":"9","author":"von Jonquieres","year":"2016","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.omtm.2025.101588_bib14","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0378-1119(03)00675-9","article-title":"Cloning and characterization of the rat myelin basic protein gene promoter","volume":"313","author":"Wei","year":"2003","journal-title":"Gene"},{"key":"10.1016\/j.omtm.2025.101588_bib15","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23105746","article-title":"Keeping Excitation-Inhibition Ratio in Balance","volume":"23","author":"Kirischuk","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.omtm.2025.101588_bib16","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1038\/ejhg.2015.216","article-title":"Imbalance of excitatory\/inhibitory synaptic protein expression in iPSC-derived neurons from FOXG1+\/\u2212 patients and in foxg1+\/\u2212 mice","volume":"24","author":"Patriarchi","year":"2016","journal-title":"Eur. J. Hum. Genet."},{"key":"10.1016\/j.omtm.2025.101588_bib17","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/j.neuron.2015.07.033","article-title":"Excitatory\/Inhibitory Balance and Circuit Homeostasis in Autism Spectrum Disorders","volume":"87","author":"Nelson","year":"2015","journal-title":"Neuron"},{"key":"10.1016\/j.omtm.2025.101588_bib18","article-title":"270 High-throughput discovery of constitutive promoters to drive strong expression of next-generation gene circuits in CAR-NK and -T cells","volume":"11","author":"Hua","year":"2023","journal-title":"Journal for ImmunoTherapy of Cancer"},{"key":"10.1016\/j.omtm.2025.101588_bib19","first-page":"116","article-title":"Better Targeting, Better Efficiency for Wide-Scale Neuronal Transduction with the Synapsin Promoter and AAV-PHP","volume":"9","author":"Jackson","year":"2016","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.omtm.2025.101588_bib20","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.omtm.2023.05.013","article-title":"Strong ubiquitous micro-promoters for recombinant adeno-associated viral vectors","volume":"29","author":"Chai","year":"2023","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.omtm.2025.101588_bib21","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1126\/science.8303295","article-title":"Green fluorescent protein as a marker for gene expression","volume":"263","author":"Chalfie","year":"1994","journal-title":"Science"},{"key":"10.1016\/j.omtm.2025.101588_bib22","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1146\/annurev.biochem.67.1.509","article-title":"The green fluorescent protein","volume":"67","author":"Tsien","year":"1998","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.omtm.2025.101588_bib23","doi-asserted-by":"crossref","first-page":"E3343","DOI":"10.1073\/pnas.1410893111","article-title":"Astrocytes contribute to gamma oscillations and recognition memory","volume":"111","author":"Lee","year":"2014","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omtm.2025.101588_bib24","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.cell.2018.05.002","article-title":"Astrocytic Activation Generates De Novo Neuronal Potentiation and Memory Enhancement","volume":"174","author":"Adamsky","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.omtm.2025.101588_bib25","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1186\/s13041-021-00865-9","article-title":"S100B is selectively expressed by gray matter protoplasmic astrocytes and myelinating oligodendrocytes in the developing CNS","volume":"14","author":"Du","year":"2021","journal-title":"Mol. Brain"},{"key":"10.1016\/j.omtm.2025.101588_bib26","doi-asserted-by":"crossref","DOI":"10.4172\/2155-9562.1000326","article-title":"Neuroanatomical Mapping of s100 Immunoreactivity Reviewed","volume":"06","author":"Campos","year":"2015","journal-title":"J. Neurol. Neurophysiol."},{"key":"10.1016\/j.omtm.2025.101588_bib27","article-title":"AAV9\/SLC6A1 gene therapy rescues abnormal EEG patterns and cognitive behavioral deficiencies in Slc6a1-\/- mice","volume":"135","author":"Guo","year":"2024","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.omtm.2025.101588_bib28","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1038\/s41434-020-0178-0","article-title":"Transduction patterns in the CNS following various routes of AAV-5-mediated gene delivery","volume":"28","author":"Pietersz","year":"2021","journal-title":"Gene Ther."},{"key":"10.1016\/j.omtm.2025.101588_bib29","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.omtm.2018.08.005","article-title":"A Direct Comparison of IV and ICV Delivery Methods for Gene Replacement Therapy in a Mouse Model of SMARD1","volume":"10","author":"Shababi","year":"2018","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.omtm.2025.101588_bib30","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.3390\/cells12121619","article-title":"A Novel Small NPC1 Promoter Enhances AAV-Mediated Gene Therapy in Mouse Models of Niemann\u2013Pick Type C1 Disease","volume":"12","author":"Hughes","year":"2023","journal-title":"Cells"},{"key":"10.1016\/j.omtm.2025.101588_bib31","doi-asserted-by":"crossref","first-page":"S47","DOI":"10.1016\/j.nmd.2021.07.018","article-title":"CLINICAL TRIAL HIGHLIGHTS: O.1 ASPIRO gene therapy trial in X-linked myotubular myopathy (XLMTM): update on preliminary efficacy and safety findings","volume":"31","author":"Shieh","year":"2021","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.omtm.2025.101588_bib32","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1016\/S1474-4422(23)00416-7","article-title":"Gene therapy for X-linked myotubular myopathy: the challenges","volume":"22","author":"Voermans","year":"2023","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.omtm.2025.101588_bib33","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.neulet.2014.05.044","article-title":"Widespread neuron-specific transgene expression in brain and spinal cord following synapsin promoter-driven AAV9 neonatal intracerebroventricular injection","volume":"576","author":"McLean","year":"2014","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.omtm.2025.101588_bib34","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1158\/1541-7786.MCR-13-0244","article-title":"Cancer Gene Discovery: Exploiting Insertional Mutagenesis","volume":"11","author":"Ranzani","year":"2013","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.omtm.2025.101588_bib35","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0065646","article-title":"Glial promoter selectivity following AAV-delivery to the immature brain","volume":"8","author":"von Jonquieres","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.omtm.2025.101588_bib36","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1002\/elps.1150180333","article-title":"A comparison of selected mRNA and protein abundances in human liver","volume":"18","author":"Anderson","year":"1997","journal-title":"Electrophoresis"},{"key":"10.1016\/j.omtm.2025.101588_bib37","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/nature05453","article-title":"Genome-wide atlas of gene expression in the adult mouse brain","volume":"445","author":"Lein","year":"2007","journal-title":"Nature"}],"container-title":["Molecular Therapy Methods & Clinical Development"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2329050125001834?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2329050125001834?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T20:30:35Z","timestamp":1776198635000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2329050125001834"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":37,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["S2329050125001834"],"URL":"https:\/\/doi.org\/10.1016\/j.omtm.2025.101588","relation":{},"ISSN":["2329-0501"],"issn-type":[{"value":"2329-0501","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparative analysis of cell-specific promoters in AAV9-mediated gene therapy targeting the central nervous system","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy Methods & Clinical Development","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.omtm.2025.101588","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc. on behalf of The American Society of Gene and Cell Therapy.","name":"copyright","label":"Copyright"}],"article-number":"101588"}}